#PACB
PACB +559% in 202 days. Pacific Biosciences cleared its 4.24 pivot with a 4.73 close in August 2020, hit 53.69 in February and exited at 31.18. The full analysis of the trade: https://trendsandbreakouts.com/pacb-base-breakout-august-2020 #PACB #stocks #breakout
PACB +559%: a post-crash base breakout in genomics, August 2020
PACB +559% in 202 days. Pacific Biosciences cleared its 4.24 pivot with a 4.73 close in August 2020, hit 53.69 in February and exited at 31.18. The full analysis of the trade: https://trendsandbreakouts.com/pacb-base-breakout-august-2020 #PACB #stocks #breakout
trendsandbreakouts.com
November 15, 2026 at 8:13 PM
🚨 $PACB
KATHY PALMER ORDONEZ, a Director, filed a notice of intent to sell 18,595 shares of common stock, valued at approximately $33,093.52, on 11/17/2026.
SEC Filing: PACB
Click to view the official SEC document.
www.sec.gov
November 17, 2026 at 9:37 PM
PACB +559% in 202 days — the full trade story is on the blog. An educational look back at one real historical trade. Not financial advice. #trading #stocks #breakout #FinTok #technicalanalysis
November 15, 2026 at 8:18 PM
Pacific Biosciences of California ($PACB) – New 13G stake

• Holder: Goldman Sachs
• Stake: 0 → 7.6% (about $55M)
• About 13G: a passive investor, not seeking to influence the company

📊 More at www.elixstocks.com

Educational only. Not investment advice.

#Investing #Stocks
Goldman Sachs Group Inc: 7.6% of Pacific Biosciences of California ($PACB)
Filed Nov 9. Who filed, the stake, and how it changed.
elixstocks.com
November 10, 2026 at 9:33 PM
SELL $PACB (PACB.O) [StockDilution] Other Securities Offering; Filed @ 21:52:44Z
November 10, 2026 at 9:52 PM
Dilution watch, filings Tue Nov 10 to Wed Nov 11 (names we alerted in the last 90 days): $PMI priced an offering; $PACB priced an offering; $PRME priced an offering; $SCNI priced an offering. Not financial advice.
https://momometer.com/go/bluesky/dilution_watch
November 11, 2026 at 12:15 PM
November 9, 2026 at 2:30 PM
$PACB: PacBio grew Q3 revenue to $40.6M from $38.4M, with instrument revenue of $13.2M; net loss was $37.8M ($0.12/share). Not investment advice.

https://www.merlintrader.com/pacific-biosciences-pacb-stock-hub/
November 8, 2026 at 3:45 PM
Pacific Biosciences of California ($PACB) – New 13G stake

• Holder: Price T Rowe Associates Inc /MD/
• Stake: 0 → 10.8% (about $81M)
• About 13G: a passive investor, not seeking to influence the company

📊 More at www.elixstocks.com

Educational only. Not investment advice.

#Investing #Stocks
Price T Rowe Associates Inc /md/: 10.8% of Pacific Biosciences of California ($PACB)
Filed Nov 6. Who filed, the stake, and how it changed.
elixstocks.com
November 6, 2026 at 5:14 PM
November 5, 2026 at 1:46 PM
🚨 $PACB
On November 4, 2026, Pacific Biosciences of California, Inc. announced its financial results for its third fiscal quarter ended September 30, 2026. A copy of the press release containing the announcement is attached as Exhibit 99.1 hereto and is incorporated herein by reference.
SEC Filing: PACB
Click to view the official SEC document.
www.sec.gov
November 4, 2026 at 9:24 PM
#$PACB earnings after close Wed Nov 4, call 4:30 PM ET Wed Nov 4: investor.pacb.com
$2.48, above SMA50 ($1.87), above SMA200, RSI 57.
Chart, bull/bear scenarios: justcharts.merlintrader.com#PACB
Not investment advice.
November 3, 2026 at 11:02 PM
🏹 ARK 11/4 trades:
🟢 Buys: #$SPCX in ARKK, ARKQ, ARKW (~0.5% each), #$NRIX, #$ILMN, #$PACB, #$TWST
🔴 Sells: #$GOOG, #$AMZN, #$LLY, #$CRWD, #$NET, #$BLSH
🔄 ARKQ swapped $AMZN/$GOOG into #$SPCX.
📊 Biotech tilt: genomics tools in, diagnostics out (#$PSNL, #$CDNA).
👀 Conviction or lock-up dip-buying? Stay staged.
November 5, 2026 at 1:23 AM
🔄 Cathie Wood’s ARK rebalance 11/2: BUY 🟢 #$COIN #$CRCL #$HOOD, #$ILMN #$PACB #$TWST. SELL 🔴 #$BLSH, #$TEM, #$PSNL, #$CDNA. Crypto rotation: Bullish out, Coinbase & Circle in 🪙 Genomics: diagnostics out, sequencing tools in 🧬 Small trims, not panic. @ARKInvest @coinbase [NOT FINANCIAL ADVICE, DYOR!]
November 3, 2026 at 1:35 AM
#$PACB weekly close $2.60 (+23.5% w/w), above SMA50 $1.83 / above SMA200 $1.61, RSI 61.2. Support $1.70, resistance $3.44. Broad market sell-off Friday.

New hub updated: www.merlintrader.com/pacific-bios...
October 31, 2026 at 7:56 PM
#$PACB weekly close $2.60 (+23.5% w/w), above SMA50 $1.83 / above SMA200 $1.61, RSI 61.2. Support $1.70, resistance $3.44. Broad market sell-off Friday.

New hub updated: www.merlintrader.com/pacific-bios...
October 31, 2026 at 7:56 PM
🐳 @CathieDWood ARK rebalance Oct 26 🔄
🟢 BUYS: #$ACHR #$JOBY (eVTOL) 🚁 #$AVAV #$KTOS (drones/defense) 🛰️ #$KDK #$CRCL #$NU #$MELI #$PACB
🔴 SELLS: #$AMD #$TSM (profit-taking) 💰 #$ARKB bitcoin ETF ₿
Theme: autonomy, defense, trim semis, bitcoin 🧠
@ARKInvest
Small trades (<1% of each fund): rebalancing
October 27, 2026 at 12:18 AM
🧬 CATHIE WOOD'S REBALANCE: 14 sells, 4 buys — every buy is genomics. ARK sold #$GOOG hardest (0.35% of #$ARKK), trimmed #$PLTR, #$NET, #$SHOP, sold #$CRWD into its +8% spike — bought #$PACB in two funds, plus #$FRNM, #$SCTX. Platform winners fund the gene basket. [NOT FINANCIAL ADVICE, DYOR!]
October 24, 2026 at 12:44 AM
📈 Closed trade: $PACB (Pacific Biosciences) — +18.5% in 3 days

Entry $1.78 (Oct 19, 2026) → Exit $2.13 (Oct 22, 2026). The system entered on signal and exited on signal — no emotion, no hesitation.

https://daloop.com/?utm_source=bluesky&utm_campaign=evening
October 22, 2026 at 10:07 PM
🚨 @CathieDWood’s @ARKInvest rebalanced Oct 22! 🟢 Bought #$META across ARKK, ARKW and ARKF (~0.24–0.29% each) 🔴 Sold #$TER, #$SHOP, #$RBLX, #$XYZ, #$PLTR 🧬 ARKG loaded #$SCTX, #$FRNM, #$PACB, #$IAM ⚖️ Meta swap is nearly size-matched in ARKW: ~0.24% bought, ~0.24% sold. Conviction or housekeeping? 🤔 Rotation.
October 23, 2026 at 12:28 AM